Charles Explorer logo
🇬🇧

End of life of haemato-oncological patients in the Czech Republic in 2020

Publication at First Faculty of Medicine |
2020

Abstract

In the following text I am describing the end of life and dying of haemato-oncological patients at present and care for them. I am presenting the historical context and the current situation in the Czech Republic.

The focus is on the peculiarities of a haemato-oncological patient at the end of life compared to other patients in the terminal state. The article also includes a reflection on the extent to which we are able to measure the quality of care at the end of life and what tools are used for this measurement.

Based on the personal experience of the author and literature, I am summarising the influences that affect the trajectory of a hemato-oncological patient in the health system. I emphasize the role of communication between physician and patient, the influence of which may be greater than cultural patterns or specifics of haematological disease.

In the final part some common complications specific for haemato-oncological patients and recommended approach to their solution are presented.